Cognition Therapeutics, Inc. (CGTX)
NCM – Real vaqt narxi. Valyuta: USD
1.18
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.16
-0.02 (-1.69%)
Bozor oldidan: May 13, 2026, 4:20 AM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
1.18
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.16
-0.02 (-1.69%)
Bozor oldidan: May 13, 2026, 4:20 AM EDT
Cognition Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, yoshga bog'liq degenerativ kasalliklar va markaziy asab tizimi hamda retinaning buzilishlarini maqsad qilib olgan kichik molekulali dorilarni kashf qilish va ishlab chiqish bilan shug'ullanadi. Uning yetakchi mahsulot nomzodi zervimesine bo'lib, bu neyron sinapslarini himoya qilish uchun og'iz orqali yuboriladigan kichik molekuladir, u patogen oqsillar oligomerlarining bog'lanishini oldini olish orqali amalga oshiriladi. Ushbu dori Altsgeymer kasalligi va engil kognitiv buzilishlar, shuningdek, quruq yoshga bog'liq makula degeneratsiyasi va Lewy jismlari bilan demensiyaga ikkilamchi bo'lgan geografik atrofiya uchun 2-bosqichli klinik tadqiqotlarda. Cognition Therapeutics, Inc. 2007 yilda tashkil etilgan va Nyu-Yorkning Purchase shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Anthony O. Caggiano M.D., Ph.D. | Chief Medical Officer |
| Dr. Steven A. Weissman Ph.D. | VP & Head of CMC |
| Mr. Bobby Horn | Corporate Controller |
| Mr. John Brendan Doyle | Chief Financial Officer |
| Ms. Anita Cornet | Head of Quality |
| Ms. Lisa Ricciardi | CEO, President & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 10-Q | cgtx-20260331x10q.htm |
| 2026-05-07 | 8-K | tm2613845d1_8k.htm |
| 2026-04-27 | DEFA14A | tm261513d3_defa14a.htm |
| 2026-04-27 | DEF 14A | tm261513-1_def14a.htm |
| 2026-03-26 | 8-K | tm269805d1_8k.htm |
| 2026-03-26 | 10-K | cgtx-20251231x10k.htm |
| 2026-03-02 | 8-K | tm267638d1_8k.htm |
| 2026-01-27 | 8-K | tm264096d1_8k.htm |
| 2025-12-18 | 8-K | tm2533712d1_8k.htm |
| 2025-11-06 | 8-K | tm2530237d1_8k.htm |